PBCC 2025 Washington, DC Orserdu (elacestrant) – For patients with ER+/HER2-, ESR1-mutated mBC, upon progression on 1L ET + CDK4/6i

Stay up to date on the latest for Perspectives In Breast Cancer Care Seminar by entering your email address below.

Disclaimer: Entering your email address here will automatically subscribe you to future email communications from MedscapeLIVE events. This does not qualify as a registration for the conference. Please follow the links for registration to ensure your spot for Perspectives In Breast Cancer Care Seminar.

Agenda